Small Canadian firm hopeful for U.S. flu vaccine contract next year

02/23/2005 | Reuters

ID Biomedical may not be able to sell its flu vaccine to the U.S. in time for the current season or for the 2005-2006 season, but CEO Tony Holler said he is optimistic the firm will get approval to supply Fluviral for the 2006-2007 flu season. The FDA still needs to inspect the company's facilities and approve its proposals for clinical trials for its vaccine.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC